EGFR and lung adenocarcinoma: Given that lung adenocarcinoma with EGFR-tyrosine kinase inhibitor (TKI) sensitizing mutation (mEGFR) is common in light and/or non-smokers, Asians, and women, it is expected to have mutational pressures other than cigarette smoking, [12].